Literature DB >> 21047554

BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse.

Verna Louhivuori1, Annalisa Vicario, Marko Uutela, Tomi Rantamäki, Lauri M Louhivuori, Eero Castrén, Enrico Tongiorgi, Karl E Akerman, Maija L Castrén.   

Abstract

Fragile X syndrome (FXS) is a common cause of inherited mental retardation and the best characterized form of autistic spectrum disorders. FXS is caused by the loss of functional fragile X mental retardation protein (FMRP), which leads to abnormalities in the differentiation of neural progenitor cells (NPCs) and in the development of dendritic spines and neuronal circuits. Brain-derived neurotrophic factor (BDNF) and its TrkB receptors play a central role in neuronal maturation and plasticity. We studied BDNF/TrkB actions in the absence of FMRP and show that an increase in catalytic TrkB expression in undifferentiated NPCs of Fmr1-knockout (KO) mice, a mouse model for FXS, is associated with changes in the differentiation and migration of neurons expressing TrkB in neurosphere cultures and in the developing cortex. Aberrant intracellular calcium responses to BDNF and ATP in subpopulations of differentiating NPCs combined with changes in the expression of BDNF and TrkB suggest cell subtype-specific alterations during early neuronal maturation in the absence of FMRP. Furthermore, we show that dendritic targeting of Bdnf mRNA was increased under basal conditions and further enhanced in cortical layer V and hippocampal CA1 neurons of Fmr1-KO mice by pilocarpine-induced neuronal activity represented by convulsive seizures, suggesting that BDNF/TrkB-mediated feedback mechanisms for strengthening the synapses were compromised in the absence of FMRP. Pilocarpine-induced seizures caused an accumulation of Bdnf mRNA transcripts in the most proximal segments of dendrites in cortical but not in hippocampal neurons of Fmr1-KO mice. In addition, BDNF protein levels were increased in the hippocampus but reduced in the cortex of Fmr1-KO mice in line with regional differences of synaptic plasticity in the brain of Fmr1-KO mice. Altogether, the present data suggest that alterations in the BDNF/TrkB signaling modulate brain development and impair synaptic plasticity in FXS. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047554     DOI: 10.1016/j.nbd.2010.10.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  38 in total

Review 1.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

2.  Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.

Authors:  Craig A Erickson; Logan K Wink; Balmiki Ray; Maureen C Early; Elizabeth Stiegelmeyer; Lauren Mathieu-Frasier; Vanessa Patrick; Debomoy K Lahiri; Christopher J McDougle
Journal:  Psychopharmacology (Berl)       Date:  2013-02-24       Impact factor: 4.530

3.  Severity of ASD symptoms and their correlation with the presence of copy number variations and exposure to first trimester ultrasound.

Authors:  Sara Jane Webb; Michelle M Garrison; Raphael Bernier; Abbi M McClintic; Bryan H King; Pierre D Mourad
Journal:  Autism Res       Date:  2016-09-01       Impact factor: 5.216

4.  Transient receptor potential channels and their role in modulating radial glial-neuronal interaction: a signaling pathway involving mGluR5.

Authors:  Lauri M Louhivuori; Linda Jansson; Pauli M Turunen; Maria H Jäntti; Tommy Nordström; Verna Louhivuori; Karl E Åkerman
Journal:  Stem Cells Dev       Date:  2014-12-17       Impact factor: 3.272

5.  Distinct role of 5'UTR sequences in dendritic trafficking of BDNF mRNA: additional mechanisms for the BDNF splice variants spatial code.

Authors:  Andrea Colliva; Enrico Tongiorgi
Journal:  Mol Brain       Date:  2021-01-12       Impact factor: 4.041

6.  Delayed Maturation of Fast-Spiking Interneurons Is Rectified by Activation of the TrkB Receptor in the Mouse Model of Fragile X Syndrome.

Authors:  Toshihiro Nomura; Timothy F Musial; John J Marshall; Yiwen Zhu; Christine L Remmers; Jian Xu; Daniel A Nicholson; Anis Contractor
Journal:  J Neurosci       Date:  2017-10-16       Impact factor: 6.167

7.  Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761®) after permanent ischemic stroke in mice.

Authors:  Shadia E Nada; Jatin Tulsulkar; Zahoor A Shah
Journal:  Mol Neurobiol       Date:  2013-10-24       Impact factor: 5.590

8.  Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.

Authors:  Claudia Bagni; Flora Tassone; Giovanni Neri; Randi Hagerman
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

9.  Trajectories of early brain volume development in fragile X syndrome and autism.

Authors:  Heather Cody Hazlett; Michele D Poe; Amy A Lightbody; Martin Styner; James R MacFall; Allan L Reiss; Joseph Piven
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-08-01       Impact factor: 8.829

10.  Genetic removal of matrix metalloproteinase 9 rescues the symptoms of fragile X syndrome in a mouse model.

Authors:  Harpreet Sidhu; Lorraine E Dansie; Peter W Hickmott; Douglas W Ethell; Iryna M Ethell
Journal:  J Neurosci       Date:  2014-07-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.